A deep learning framework assisted echocardiography with diagnosis, lesion localization, phenogrouping heterogeneous disease, and anomaly detection.

Journal: Scientific reports
PMID:

Abstract

Echocardiography is the first-line diagnostic technique for heart diseases. Although artificial intelligence techniques have made great improvements in the analysis of echocardiography, the major limitations remain to be the built neural networks are normally adapted to a few diseases and specific equipment. Here, we present an end-to-end deep learning framework named AIEchoDx that differentiates four common cardiovascular diseases (Atrial Septal Defect, Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, prior Myocardial Infarction) from normal subjects with performance comparable to that of consensus of three senior cardiologists in AUCs (99.50% vs 99.26%, 98.75% vs 92.75%, 99.57% vs 97.21%, 98.52% vs 84.20%, and 98.70% vs 89.41%), respectively. Meanwhile, AIEchoDx accurately recognizes critical lesion regions of interest along with each disease by visualizing the decision-making process. Furthermore, our analysis indicates that heterogeneous diseases, like dilated cardiomyopathy, could be classified into two phenogroups with distinct clinical characteristics. Finally, AIEchoDx performs efficiently as an anomaly detection tool when applying handheld device-produced videos. Together, AIEchoDx provides a potential diagnostic assistant tool in either cart-based echocardiography equipment or handheld echocardiography device for primary and point-of-care medical personnel with high diagnostic performance, and the application of lesion region identification and heterogeneous disease phenogrouping, which may broaden the application of artificial intelligence in echocardiography.

Authors

  • Bohan Liu
    Medical Big Data Research Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
  • Hao Chang
    Department of Genetics, Yale Cancer Center, Howard Hughes Medical Institute, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT, 06510, USA.
  • Dong Yang
    College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology Xi'an 710021 China yangdong@sust.edu.cn.
  • Feifei Yang
    Center for Control and Optimization, School of Automation Science and Engineering, South China University of Technology, Guangzhou 510641, China.
  • Qiushuang Wang
    Medical Big Data Research Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
  • Yujiao Deng
    Medical Big Data Research Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
  • Lijun Li
    Department of Orthopedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, PR China; Orthopedics Research Institute of Zhejiang University, Hangzhou, 310000, PR China; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou City, Zhejiang Province, PR China. Electronic address: lilijun@zju.edu.cn.
  • Wenqing Lv
    Department of Cardiology, Beijing Tongren Hospital, Beijing, 100176, China.
  • Bo Zhang
    Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, PR China.
  • Liheng Yu
    The 980th Hospital of PLA Joint Logistical Support Force (Bethune International Peace Hospital), Shijiazhuang, Hebei, 050082, China.
  • Daniel Burkhoff
    Division of Cardiology Columbia University New York NY USA.
  • Kunlun He
    Beijing Key Laboratory of Precision Medicine for Chronic Heart Failure, Chinese PLA General Hospital, Beijing, China.